NOVARTIS INDIA LTD. - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

Download	< Back
20 Dec 2021
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Mr. Felix Doss has tendered his resignation from the position of Chief Financial Officer of the Company, to pursue opportunities outside of Novartis. The resignation has been accepted and he will be relieved from his responsibilities at the end of business hours on December 31, 2021. The Company is in the process of identifying a suitable successor and the same will be communicated to the stock exchange, once the position is filled up. Kindly take note of the above on record.
View all announcements for NOVARTIS INDIA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us